Literature DB >> 22977368

Coping with Brain Disorders using Neurotechnology.

Valdes-Sosa Pedro A1.   

Abstract

Brain disorders account for more than 34% of the global burden of disease, crippling nations by decreasing their "mental capital"-with greater effect in developing countries. Early detection is the key to their management, but establishing such programmes seems nearly impossible due to the high prevalence of the dysfunctions as compared with the high cost of neuroimaging devices. Thus, at first sight, the research of the Decade of the Brain and the international Human Brain Mapping Project might seem to be condemned to benefit only a small elite. Cuba has shown that is not so by using neurotechnology for the last 3 decades to implement stratified active screening programmes for brain disorders at the population level. This experience has shown that, by the transformation of health indicators, an appropriate use of technology can be integrated with attention to the population at the primary levels of both health care and education. An essential component of neurotechnology is neuroinformatics, which-like its counterpart bioinformatics-combines databases, analysis tools, and theoretical models to craft tools for early disease diagnosis and management. Much work remains to be done and will depend critically on south-south cooperation to solve problems for countries with similar situations.

Entities:  

Keywords:  brain disorders; international cooperation; medical informatics; neuroimaging; neurosciences; technology

Year:  2012        PMID: 22977368      PMCID: PMC3436487     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  4 in total

1.  A 25-Year Review of Cuba's Screening Program for Early Detection of Hearing Loss.

Authors:  María Cecilia Pérez; José Antonio Gaya; Guillermo Savio; Maritza Perera; Maribel Ponce de León; Manuel Sánchez
Journal:  MEDICC Rev       Date:  2009-01       Impact factor: 0.583

Review 2.  The size and burden of mental disorders and other disorders of the brain in Europe 2010.

Authors:  H U Wittchen; F Jacobi; J Rehm; A Gustavsson; M Svensson; B Jönsson; J Olesen; C Allgulander; J Alonso; C Faravelli; L Fratiglioni; P Jennum; R Lieb; A Maercker; J van Os; M Preisig; L Salvador-Carulla; R Simon; H-C Steinhausen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09       Impact factor: 4.600

3.  Latin American Brain Mapping Network (LABMAN).

Authors:  K Uludağ; A C Evans; V Della-Maggiore; S Kochen; E Amaro; O Sierra; P Valdés-Hernandez; V Medina; P Valdés-Sosa
Journal:  Neuroimage       Date:  2009-03-24       Impact factor: 6.556

4.  The mental wealth of nations.

Authors:  John Beddington; Cary L Cooper; John Field; Usha Goswami; Felicia A Huppert; Rachel Jenkins; Hannah S Jones; Tom B L Kirkwood; Barbara J Sahakian; Sandy M Thomas
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

  4 in total
  4 in total

1.  Letter to the editor: a new start with fMRI.

Authors:  Win Mar Salmah Jalaluddin; Ahmad Helmy Abdul Karim; Munirah Che Abdullah; Mohd Shafie Abdullah; Siti Afidah Hamat; Wan Nazyrah Abdul Halim; Alwani Liyana Ahmad; Nor Safira Elaina Mohd Noor; Aini Ismafairus Abd Hamid; Hoshiang Chueh
Journal:  Malays J Med Sci       Date:  2012-04

2.  Letter to the editor: Comparative cognitive neuroscience: non-human primate study in the understanding of human appreciation of colours.

Authors:  Mohamed Faiz Mohamed Mustafar
Journal:  Malays J Med Sci       Date:  2012-04

3.  Another Important News from the Neuronman: Malaysia's Neuroscience Group Moves upwards in Terms of Research, Creativity, and Innovation.

Authors:  Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2015-12

Review 4.  Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview.

Authors:  Khurshid Ahmad; Mohammad Hassan Baig; Gohar Mushtaq; Mohammad Amjad Kamal; Nigel H Greig; Inho Choi
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.